Application Nr Approved Date Route Status External Links
NDA212097 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Gvoke Is Indicated For The Treatment Of Severe Hypoglycemia In Pediatric And Adult Patients With Diabetes Ages 2 Years And Above. Gvoke Is An Antihypoglycemic Agent Indicated For The Treatment Of Severe Hypoglycemia In Pediatric And Adult Patients With Diabetes Ages 2 Years And Above. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Glucagon

Comments